Transcatheter aortic valve implantation amid the COVID-19 pandemic: a nationwide analysis of the first COVID-19 wave in the Netherlands.
Aortic valve stenosis
COVID-19
Postoperative complications
Registries
Transcatheter aortic valve implantation
Treatment outcome
Journal
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
ISSN: 1568-5888
Titre abrégé: Neth Heart J
Pays: Netherlands
ID NLM: 101095458
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
accepted:
15
05
2022
pubmed:
2
6
2022
medline:
2
6
2022
entrez:
1
6
2022
Statut:
ppublish
Résumé
The coronavirus disease 2019 (COVID-19) pandemic has put tremendous pressure on healthcare systems. Most transcatheter aortic valve implantation (TAVI) centres have adopted different triage systems and procedural strategies to serve highest-risk patients first and to minimise the burden on hospital logistics and personnel. We therefore assessed the impact of the COVID-19 pandemic on patient selection, type of anaesthesia and outcomes after TAVI. We used data from the Netherlands Heart Registration to examine all patients who underwent TAVI between March 2020 and July 2020 (COVID cohort), and between March 2019 and July 2019 (pre-COVID cohort). We compared patient characteristics, procedural characteristics and clinical outcomes. We examined 2131 patients who underwent TAVI (1020 patients in COVID cohort, 1111 patients in pre-COVID cohort). EuroSCORE II was comparable between cohorts (COVID 4.5 ± 4.0 vs pre-COVID 4.6 ± 4.2, p = 0.356). The number of TAVI procedures under general anaesthesia was lower in the COVID cohort (35.2% vs 46.5%, p < 0.001). Incidences of stroke (COVID 2.7% vs pre-COVID 1.7%, p = 0.134), major vascular complications (2.3% vs 3.4%, p = 0.170) and permanent pacemaker implantation (10.0% vs 9.4%, p = 0.634) did not differ between cohorts. Thirty-day and 150-day mortality were comparable (2.8% vs 2.2%, p = 0.359 and 5.2% vs 5.2%, p = 0.993, respectively). During the COVID-19 pandemic, patient characteristics and outcomes after TAVI were not different than before the pandemic. This highlights the fact that TAVI procedures can be safely performed during the COVID-19 pandemic, without an increased risk of complications or mortality.
Identifiants
pubmed: 35648264
doi: 10.1007/s12471-022-01704-9
pii: 10.1007/s12471-022-01704-9
pmc: PMC9158307
doi:
Types de publication
Journal Article
Langues
eng
Pagination
503-509Informations de copyright
© 2022. The Author(s).
Références
Søreide K, Hallet J, Matthews JB, et al. Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. Br J Surg. 2020;107(10):1250–61.
doi: 10.1002/bjs.11670
pubmed: 32350857
pmcid: 7267363
Gaudino M, Chikwe J, Hameed I, Robinson NB, Fremes SE, Ruel M. Response of cardiac surgery units to COVID-19: an internationally-based quantitative survey. Circulation. 2020;142(3):300–2.
doi: 10.1161/CIRCULATIONAHA.120.047865
pubmed: 32392425
pmcid: 7365675
Kapadia SR, Leon MB, Makkar RR, et al. 5‑year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2485–91.
doi: 10.1016/S0140-6736(15)60290-2
pubmed: 25788231
Malaisrie SC, McDonald E, Kruse J, et al. Mortality while waiting for aortic valve replacement. Ann Thorac Surg. 2014;98(5):1564–70. discussion 70–71.
doi: 10.1016/j.athoracsur.2014.06.040
pubmed: 25240781
Martin GP, Curzen N, Goodwin AT, et al. Indirect impact of the COVID-19 pandemic on activity and outcomes of transcatheter and surgical treatment of aortic stenosis in England. Circ Cardiovasc Interv. 2021;14(5):e10413.
doi: 10.1161/CIRCINTERVENTIONS.120.010413
pubmed: 34003671
pmcid: 8126473
Tay EL, Hayashida K, Chen M, et al. Transcatheter aortic valve implantation during the COVID-19 pandemic: clinical expert opinion and consensus statement for Asia. J Card Surg. 2020;35(9):2142–6.
doi: 10.1111/jocs.14722
pubmed: 32720374
Shah PB, Welt FGP, Mahmud E, et al. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: an ACC/SCAI position statement. JACC Cardiovasc Interv. 2020;13(12):1484–8.
doi: 10.1016/j.jcin.2020.04.001
pubmed: 32250751
pmcid: 7270905
Tanguturi VK, Lindman BR, Pibarot P, et al. Managing severe aortic stenosis in the COVID-19 era. JACC Cardiovasc Interv. 2020;13(16):1937–44.
doi: 10.1016/j.jcin.2020.05.045
pubmed: 32484159
pmcid: 7263810
Lauck S, Forman J, Borregaard B, et al. Facilitating transcatheter aortic valve implantation in the era of COVID-19: recommendations for programmes. Eur J Cardiovasc Nurs. 2020;19(6):537–44.
doi: 10.1177/1474515120934057
pubmed: 32498556
pmcid: 7717283
Rooijakkers MJP, Li WWL, Wollersheim L, et al. Transcatheter aortic valve replacement during the COVID-19 pandemic: a Dutch single-center analysis. J Card Surg. 2021;36(1):48–55.
doi: 10.1111/jocs.15123
pubmed: 33084121
Vendrik J, de Boer J, Zwiers W, et al. Ongoing transcatheter aortic valve implantation (TAVI) practice amidst a global COVID-19 crisis: nurse-led analgesia for transfemoral TAVI. Neth Heart J. 2020;28(7–8):384–6.
doi: 10.1007/s12471-020-01472-4
pubmed: 32662057
pmcid: 7357262
NHR Handboeken & overige documenten. https://nederlandsehartregistratie.nl/handboeken/ . Accessed 28 Apr 2022.
Wetenschappelijk beleid van de NHR. http://nederlandsehartregistratie.nl/wp-content/uploads/2022/01/NHR-wetenschappelijk-beleid_versie-6.0.pdf . Accessed 28 Apr 2022.
RIVM Coronadashboard. https://coronadashboard.rijksoverheid.nl/landelijk/positief-geteste-mensen . Accessed 28 Apr 2022.
Généreux P, Piazza N, Alu MC, et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J. 2021;42(19):1825–57.
doi: 10.1093/eurheartj/ehaa799
pubmed: 33871579
Adlam D, Chan N, Baron J, Kovac J. Aortic stenosis in the time of COVID-19: development and outcomes of a rapid turnaround TAVI service. Catheter Cardiovasc Interv. 2021;98(3):e478–82.
doi: 10.1002/ccd.29550
pubmed: 33565703
pmcid: 8014719
Valdebenito M, Massalha E, Barbash IM, et al. Transcatheter aortic valve implantation during the COVID-19 Pandemic. Am J Cardiol. 2021;145:97–101.
doi: 10.1016/j.amjcard.2020.12.086
pubmed: 33454341
pmcid: 7836376
Thiele H, Kurz T, Feistritzer HJ, et al. General versus local anesthesia with conscious sedation in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial. Circulation. 2020;142(15):1437–47.
doi: 10.1161/CIRCULATIONAHA.120.046451
pubmed: 32819145
Feistritzer HJ, Kurz T, Stachel G, et al. Impact of anesthesia strategy and valve type on clinical outcomes after transcatheter aortic valve replacement. J Am Coll Cardiol. 2021;77(17):2204–15.
doi: 10.1016/j.jacc.2021.03.007
pubmed: 33926657
Perdoncin E, Greenbaum AB, Grubb KJ, et al. Safety of same-day discharge after uncomplicated, minimalist transcatheter aortic valve replacement in the COVID-19 era. Catheter Cardiovasc Interv. 2021;97(5):940–7.
doi: 10.1002/ccd.29453
pubmed: 33382519
NHR Rapportage 2021. https://nederlandsehartregistratie.nl/wp-content/uploads/2021/09/NHR-Rapportage-2021-090921.pdf . Accessed 28 Apr 2022.
WHO Coronavirus (COVID-19) dashboard. https://covid19.who.int/ . Accessed 20 Apr 2022.
Denimal T, Delhaye C, Piérache A, et al. Feasibility and safety of transfemoral transcatheter aortic valve implantation performed with a percutaneous coronary intervention-like approach. Arch Cardiovasc Dis. 2021;114(8–9):537–49.
doi: 10.1016/j.acvd.2020.12.007
pubmed: 33895105